[Pain therapy with antipyretic analgesics].
The pharmacotherapy of musculoskeletal pain remains of high importance in Western countries. The present review concentrates on the use of acidic (nonsteroidal anti-inflammatory drugs) and nonacidic (paracetamol, selective cyclooxygenase-2 inhibitors) antipyretic analgesics in the therapy of musculoskeletal pain disorders with particular emphasis on the diverse pharmacokinetic properties and unwanted side effects of these substances.
Hinz
B
B
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Deutschland. hinz@pharmakologie.uni.erlangen.de
Brune
K
K
D018712:Analgesics, Non-Narcotic / Q000009:adverse effects / Q000145:classification* / Q000627:therapeutic use*; D006801:Humans; D009140:Musculoskeletal Diseases / Q000150:complications* / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'
D018712:Analgesics, Non-Narcotic